Contents Oncology


Paraneoplastic Neurologic Syndromes—An Update on Current Understanding and Future Perspectives 53 Wolfgang Grisold, MD,1


Bruno Giometto, MD,2 Stefan Oberndorfer, MD3 and Roberta Vitaliani, MD, PhD4


1. Professor and Clinician, Neurology Department, KFJ Hospital, Medical University of Vienna and Ludwig Boltzmann Institute for Neuro-oncology; 2. Head, Department of Neurology, Ca’ Foncello Hospital, Treviso; 3. Clinician, Neurology Department, KFJ Hospital, Medical University of Vienna and Ludwig Boltzmann Institute for Neuro-oncology; 4. Consultant, Department of Neurology, Ca’ Foncello Hospital, Treviso


Multiple Sclerosis


Emerging Therapies in Multiple Sclerosis—New Decisions in the Formulation of Treatment Strategies Guy J Buckle, MD, MPH


Director of Clinical Care, Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, and Assistant Professor of Neurology, Harvard Medical School


Laquinimod in Relapsing–Remitting Multiple Sclerosis Douglas R Jeffery, MD, PhD,1


Emily Pharr, MD2 70 and Nuhad Abou Zeid, MD3


1. Neurologist, Advance Neurology and Pain, Cornerstone Health Care; 2. Resident Physician; 3. Assistant Professor, Department of Neurology, Wake Forest University School of Medicine


Dalfampridine Extended Release Tablets—Clinical Need and Use Aaron Miller, MD, FAAN,1


76 Amy Perrin Ross, APN, MSN, CNRN, MSCN2 and James Gilbart, PhD3


1. Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis and Professor of Neurology, Mount Sinai School of Medicine; 2. Neuroscience Program Co-ordinator, Department of Neurosciences, Loyola University Chicago; 3. Senior Medical Writer, Touch Briefings


Alemtuzumab—A New Efficacy Benchmark in Relapsing–Remitting Multiple Sclerosis? Omar A Khan, MD


Professor of Neurology, and Director, Multiple Sclerosis Clinical Research Center and Image Analysis Laboratory, Department of Neurology, Wayne State University School of Medicine


Measuring Disability Progression with the Multiple Sclerosis Functional Composite Kristen M Krysko, HBSc1


and Paul W O’Connor, MD, MSc, FRCPC2


1. Medical Student, Class of 2012, University of Toronto; 2. Neurologist and Director, Multiple Sclerosis Clinic and Multiple Sclerosis Research, St Michael’s Hospital and Professor of Medicine (Neurology), University of Toronto


Environmental Risk Factors for Pediatric Multiple Sclerosis Naila Makhani, MD1


and Brenda Banwell, MD2


1. Fellow, Pediatric Demyelinating Disease Program, The Hospital for Sick Children and University of Toronto; 2. Associate Professor of Pediatrics (Neurology), Associate Scientist, Research Institute, and Director, Pediatric Multiple Sclerosis Clinic, The Hospital for Sick Children and University of Toronto


Rehabilitation


Technological Advances in Stroke Rehabilitation—High Tech Marries High Touch Richard C Senelick, MD


Neurologist, and Medical Director, Rehabilitation Institute of San Antonio Neuroimaging Advances in Stroke Rehabilitation


Rüdiger J Seitz, MD,1 Robert Lindenberg, MD2 and Gottfried Schlaug, MD, PhD3


1. Professor of Neurology, Department of Neurology, University Hospital Düsseldorf and Biomedical Research Centre, Heinrich-Heine-University Düsseldorf; 2. Instructor in Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, and University Hospital Düsseldorf; 3. Associate Professor of Neurology, Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School


The WalkAide® Functional Electrical Stimulation System—A Novel Therapeutic Approach For Foot Drop in Central Nervous System Disorders


Michelle H Cameron, MD, PT


Neurologist, Multiple Sclerosis Center of Excellence West, Portland Veterans Affairs Medical Center, and Assistant Professor, Department of Neurology, Multiple Sclerosis Center of Oregon, Oregon Health and Science University


8 US NEUROLOGY 112 102 96 91 82 60


105


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132